Dr Reddy's recalling Phytonadione Injectable Emulsion in US

25 Oct 2022 Evaluate

Dr Reddy's Laboratories’ US-based unit is recalling 2,838 ampules of vitamin K deficiency treatment drug Phytonadione Injectable Emulsion. According to the USFDA, the company is recalling the affected lot due to failed stability specifications.

Dr Reddy's initiated the Class III voluntary recall on September 14 this year. As per USFDA, a Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1178.00 11.10 (0.95%)
21-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.15
Dr. Reddys Lab 1178.00
Cipla 1383.00
Zydus Lifesciences 877.25
Lupin 2188.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×